Related references
Note: Only part of the references are listed.Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative
Thomas K. Karikari et al.
MOLECULAR PSYCHIATRY (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Critical Appraisal of Amyloid Lowering Agents in AD
Boris Decourt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)
Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
Kevin A. Schulman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
David S. Knopman et al.
NEUROLOGY (2021)
Revisiting FDA Approval of Aducanumab
G. Caleb Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
Billy Dunn et al.
JAMA INTERNAL MEDICINE (2021)
Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab Crisis or Opportunity?
Francis J. Crosson et al.
JAMA INTERNAL MEDICINE (2021)
Aducanumab: Appropriate Use Recommendations
J. Cummings et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
Alexandra Erath et al.
JAMA NETWORK OPEN (2020)
Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records
Andrew C. Stokes et al.
JAMA NEUROLOGY (2020)
How Much Value Would a Treatment for Alzheimer's Disease Offer? Cost-Effectiveness Thresholds for Pricing a Disease-Modifying Therapy
Hankyung Jun et al.
CURRENT ALZHEIMER RESEARCH (2020)
The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care
Bruce Pyenson et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2019)
Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
Jin-Tai Yu et al.
ALZHEIMERS & DEMENTIA (2019)
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
Colin Green et al.
ALZHEIMERS & DEMENTIA (2019)
In-hospital outcomes and 30-day readmission rates among ischemic and hemorrhagic stroke patients with delirium
Farhaan S. Vahidy et al.
PLOS ONE (2019)
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >= 65 years
Kevin A. Matthews et al.
ALZHEIMERS & DEMENTIA (2019)
Value-Based Pricing for Drugs Theme and Variations
Anna Kaltenboeck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]
Darius N. Lakdawalla et al.
VALUE IN HEALTH (2018)
Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
Rosebud O. Roberts et al.
JAMA NEUROLOGY (2018)
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?
Catherine Reed et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Contribution of Alzheimer disease to mortality in the United States
Bryan D. James et al.
NEUROLOGY (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Monetary Costs of Dementia in the United States
Michael D. Hurd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
D. Eldon Spackman et al.
Current Alzheimer Research (2012)
How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
Darius N. Lakdawalla et al.
HEALTH AFFAIRS (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients
Anders Gustavsson et al.
ALZHEIMERS & DEMENTIA (2011)
Dementia-Associated Mortality at Thirteen Years in the NEDICES Cohort Study
Alberto Villarejo et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores
Sid E. O'Bryant et al.
ARCHIVES OF NEUROLOGY (2008)
Multicomponent geriatric intervention for elderly inpatients with delirium: Effects on costs and health-related quality of life
Kaisu H. Pitkala et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2008)
Mapping scores onto stages: Mini-mental state examination and clinical dementia rating
R Perneczky et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Survival after initial diagnosis of Alzheimer disease
EB Larson et al.
ANNALS OF INTERNAL MEDICINE (2004)
A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease
PJ Neumann et al.
MEDICAL DECISION MAKING (2000)
Share Paper
